Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Neurodegeneration

Original research

Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease

Online download statistics by month:

Online download statistics by month: December 2020 to August 2023

	Abstract	Full	Pdf
Dec 2020	311	9	9
Jan 2021	2296	143	90
Feb 2021	1748	100	77
Mar 2021	1133	107	76
Apr 2021	701	64	47
May 2021	200	36	19
Jun 2021	20	17	19
Jul 2021	25	16	14
Aug 2021	20	14	10
Sep 2021	26	19	14
Oct 2021	398	19	9
Nov 2021	455	23	13
Dec 2021	379	14	7
Jan 2022	493	15	12
Feb 2022	442	15	12
Mar 2022	574	13	12
Apr 2022	350	16	15
May 2022	408	16	14
Jun 2022	279	14	9
Jul 2022	299	35	13
Aug 2022	428	22	17
Sep 2022	297	15	4
Oct 2022	301	15	11
Nov 2022	236	16	2
Dec 2022	195	9	7
Jan 2023	244	27	13
Feb 2023	186	11	5
Mar 2023	125	12	4
Apr 2023	183	11	3
May 2023	201	11	5
Jun 2023	155	18	11
Jul 2023	171	8	4
Aug 2023	229	7	5
Total	13508	887	582